GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mangalam Drugs & Organics Ltd (BOM:532637) » Definitions » E10

Mangalam Drugs & Organics (BOM:532637) E10 : ₹10.66 (As of Jun. 2024)


View and export this data going back to 2005. Start your Free Trial

What is Mangalam Drugs & Organics E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Mangalam Drugs & Organics's adjusted earnings per share data for the three months ended in Jun. 2024 was ₹1.700. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₹10.66 for the trailing ten years ended in Jun. 2024.

During the past 3 years, the average E10 Growth Rate was 21.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Mangalam Drugs & Organics was 21.60% per year. The lowest was 21.60% per year. And the median was 21.60% per year.

As of today (2024-10-31), Mangalam Drugs & Organics's current stock price is ₹111.65. Mangalam Drugs & Organics's E10 for the quarter that ended in Jun. 2024 was ₹10.66. Mangalam Drugs & Organics's Shiller PE Ratio of today is 10.47.

During the past 13 years, the highest Shiller PE Ratio of Mangalam Drugs & Organics was 31.84. The lowest was 8.78. And the median was 17.50.


Mangalam Drugs & Organics E10 Historical Data

The historical data trend for Mangalam Drugs & Organics's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mangalam Drugs & Organics E10 Chart

Mangalam Drugs & Organics Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 5.71 6.91 - 10.26

Mangalam Drugs & Organics Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 10.40 10.55 10.26 10.66

Competitive Comparison of Mangalam Drugs & Organics's E10

For the Drug Manufacturers - Specialty & Generic subindustry, Mangalam Drugs & Organics's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mangalam Drugs & Organics's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mangalam Drugs & Organics's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Mangalam Drugs & Organics's Shiller PE Ratio falls into.



Mangalam Drugs & Organics E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Mangalam Drugs & Organics's adjusted earnings per share data for the three months ended in Jun. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2024 (Change)*Current CPI (Jun. 2024)
=1.7/155.7889*155.7889
=1.700

Current CPI (Jun. 2024) = 155.7889.

Mangalam Drugs & Organics Quarterly Data

per share eps CPI Adj_EPS
201409 1.520 96.780 2.447
201412 0.640 96.780 1.030
201503 2.650 97.163 4.249
201506 2.320 99.841 3.620
201509 3.220 101.753 4.930
201512 2.400 102.901 3.634
201603 3.500 102.518 5.319
201606 2.880 105.961 4.234
201609 3.250 105.961 4.778
201612 3.850 105.196 5.702
201703 4.110 105.196 6.087
201706 2.630 107.109 3.825
201709 4.230 109.021 6.045
201712 3.780 109.404 5.383
201803 1.930 109.786 2.739
201806 0.420 111.317 0.588
201809 1.090 115.142 1.475
201812 -2.790 115.142 -3.775
201903 -3.790 118.202 -4.995
201906 0.470 120.880 0.606
201909 0.510 123.175 0.645
201912 1.040 126.235 1.283
202003 3.190 124.705 3.985
202006 5.240 127.000 6.428
202009 7.000 130.118 8.381
202012 4.070 130.889 4.844
202103 1.360 131.771 1.608
202106 2.790 134.084 3.242
202109 2.860 135.847 3.280
202112 2.540 138.161 2.864
202203 4.230 138.822 4.747
202206 1.900 142.347 2.079
202209 1.410 144.661 1.518
202212 0.000 145.763 0.000
202303 0.000 146.865 0.000
202306 0.000 150.280 0.000
202309 -8.276 151.492 -8.511
202312 0.310 152.924 0.316
202403 2.230 153.035 2.270
202406 1.700 155.789 1.700

Add all the adjusted EPS together and divide 10 will get our e10.


Mangalam Drugs & Organics  (BOM:532637) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Mangalam Drugs & Organics's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=111.65/10.66
=10.47

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Mangalam Drugs & Organics was 31.84. The lowest was 8.78. And the median was 17.50.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Mangalam Drugs & Organics E10 Related Terms

Thank you for viewing the detailed overview of Mangalam Drugs & Organics's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Mangalam Drugs & Organics Business Description

Traded in Other Exchanges
Address
P. D\'Mello Road, Rupam Building, 3rd Floor, No. 239, Near General Post Office, Mumbai, MH, IND, 400001
Mangalam Drugs & Organics Ltd is an Indian company operating in the healthcare sector. The company is engaged in the research and development and manufacturing of drugs. Its product range includes Active Pharmaceutical Ingredients (APIs), Intermediates, and Specialty chemicals. Its sales comprise sales in the Indian and overseas markets. The single operating segment of the company is the Manufacturing of Bulk Drugs.

Mangalam Drugs & Organics Headlines

No Headlines